Technical Analysis for TARS - Tarsus Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 29.3 2.59% 0.74
TARS closed up 2.59 percent on Monday, April 12, 2021, on 38 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical TARS trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Outside Day Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
MACD Bearish Signal Line Cross Bearish 2.59%
Narrow Range Bar Range Contraction 2.59%
NR7 Range Contraction 2.59%
Stochastic Reached Oversold Weakness 2.59%
Inside Day Range Contraction 2.59%
Oversold Stochastic Weakness 2.59%
Older End-of-Day Signals for TARS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above Previous Day's High about 6 hours ago
Outside Day about 6 hours ago
Down 1% about 6 hours ago
Up 1% about 6 hours ago
Fell Below Previous Day's Low about 6 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase IIb/III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. Tarsus Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Irvine, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Organ Systems Irvine Ophthalmic Anatomy Malaria Rosacea Blepharitis Meibomian Gland

Is TARS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 63.69
52 Week Low 15.32
Average Volume 32,766
200-Day Moving Average 0.00
50-Day Moving Average 34.13
20-Day Moving Average 30.72
10-Day Moving Average 29.91
Average True Range 2.28
ADX 21.73
+DI 16.15
-DI 24.28
Chandelier Exit (Long, 3 ATRs ) 27.06
Chandelier Exit (Short, 3 ATRs ) 33.84
Upper Bollinger Band 34.61
Lower Bollinger Band 26.84
Percent B (%b) 0.32
BandWidth 25.28
MACD Line -1.35
MACD Signal Line -1.38
MACD Histogram 0.0266
Fundamentals Value
Market Cap 595.39 Million
Num Shares 20.3 Million
EPS
Price-to-Sales 0.00
Price-to-Book 7.72
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 31.45
Resistance 3 (R3) 31.31 30.45 31.09
Resistance 2 (R2) 30.45 29.91 30.52 30.97
Resistance 1 (R1) 29.88 29.57 30.17 30.02 30.85
Pivot Point 29.02 29.02 29.17 29.09 29.02
Support 1 (S1) 28.45 28.48 28.74 28.59 27.75
Support 2 (S2) 27.59 28.14 27.66 27.63
Support 3 (S3) 27.02 27.59 27.51
Support 4 (S4) 27.16